Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Bio-Techne (TECH) over the last 15 years, with Q4 2025 value amounting to $11.0 million.

  • Bio-Techne's Non-Current Deferred Tax Liability fell 7078.44% to $11.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $11.0 million, marking a year-over-year decrease of 7078.44%. This contributed to the annual value of $6.2 million for FY2025, which is 8895.69% down from last year.
  • According to the latest figures from Q4 2025, Bio-Techne's Non-Current Deferred Tax Liability is $11.0 million, which was down 7078.44% from $11.3 million recorded in Q3 2025.
  • Bio-Techne's Non-Current Deferred Tax Liability's 5-year high stood at $112.9 million during Q3 2022, with a 5-year trough of $6.2 million in Q2 2025.
  • Over the past 5 years, Bio-Techne's median Non-Current Deferred Tax Liability value was $86.1 million (recorded in 2023), while the average stood at $71.0 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first soared by 1427.76% in 2022, then tumbled by 8895.69% in 2025.
  • Bio-Techne's Non-Current Deferred Tax Liability (Quarter) stood at $101.4 million in 2021, then rose by 9.82% to $111.4 million in 2022, then plummeted by 35.74% to $71.6 million in 2023, then plummeted by 47.3% to $37.7 million in 2024, then tumbled by 70.78% to $11.0 million in 2025.
  • Its Non-Current Deferred Tax Liability was $11.0 million in Q4 2025, compared to $11.3 million in Q3 2025 and $6.2 million in Q2 2025.